IceCure Medical Ltd. (ICCM): Enterprise Value to EBITDA Ratio
IceCure Medical Ltd (ICCM) is implementing eco-friendly standards in the development of cryoablation devices, reducing energy consumption and plastic use. The business generates revenue through the supply of tumor freezing systems to oncology centers for minimally invasive treatment. The confirmed price history on the EV/EBITDA chart, which currently stands at 0.00, highlights the company's expansion in the surgical segment, where it is displacing competitors through technological superiority.
Comprehensive metric breakdowns and analytics for icecure-medical.com (ICCM)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio IceCure Medical Ltd|ICCM - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity IceCure Medical|ICCM - Company Total Debt|Debts to Book Capitalization IceCure Medical Ltd|ICCM - Long-Term Debt|Company Short-Term Debts IceCure Medical|Quick Ratio icecure-medical.com
- financial results and valuation multiples details:
ICCM - Net Financial Result|Projected Future Earnings IceCure Medical Ltd|ICCM - Price to Earnings Ratio|Forward P/E Multiple IceCure Medical|ICCM - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization IceCure Medical Ltd|ICCM - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months IceCure Medical|ICCM - Earnings per share for the trailing year|Quarterly EPS earnings growth icecure-medical.com|ICCM - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year IceCure Medical Ltd
Analysis of all company metrics:IceCure Medical, Ltd. ICCM
For the innovative brand IceCure Medical Ltd (ICCM), which develops ProSense cryoablation systems, business valuation analysis requires accounting for debt load through the historical EV/EBITDA multiple. This indicator compares the total enterprise value (market capitalization and debt) with operating profit before interest, taxes, depreciation, and amortization, allowing investors to determine the asset's real price and avoid overpaying for the stock amid inflationary pressures.
Competitor analysis
Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (CONMED Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Medical (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode Ltd.)|PMI (picardmedical.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Corp - EV/EBITDA Multiple|Company Value to EBITDA Tactile Systems Technology|SNWV: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation OM|ELMD (SmartVest) - EV/EBITDA Multiple|LENSAR Inc. (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RCEL|Enterprise Value to EBITDA Ratio profoundmedical.com PROF|EV/EBITDA Multiple BDMD (Baird Medical)|EV/EBITDA Multiple EDAP TMS SA EDAP|APYX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TELA (telabio.com) - Enterprise Value to EBITDA Ratio|CytoSorbents Corporation - Business Value to Operating Income Before Depreciation|SRTS (Sensus Healthcare, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA zynex.com ZYXI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization electroCore, Inc. (ECOR)|vicarioussurgical.com (RBOT) - Enterprise Value to EBITDA Multiple|Inspira Technologies - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple SeaStar Medical Holding Corp. ICU|IRIDEX Corp. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions INBS|beyondair.net (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa Inc.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STRATA Skin Sciences Inc.|Enterprise Value to EBITDA Ratio GlucoTrack Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM: EV/EBITDA Multiple|CUTR - Total Company Value to Operating Income Before Depreciation Ratio|KNW (Know Labs) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Inari Medical Inc (NARI)|EV/EBITDA Multiple NVRO|RSLS - Company Value to EBITDA|EV/EBITDA Multiple SILK (Silk Road Medical, Inc)
